Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,009,204 ordinary shares
- Purchase Date: June 18, 2025
- Price Range: 382.90p (Low) to 386.70p (High)
- Volume Weighted Average Price: 384.87p
- Post-Transaction Share Capital: 8,993,584,706 ordinary shares
- Treasury Shares: 4,080,205
- Voting Shares: 8,989,504,501
Material Changes
The primary material change is the reduction of outstanding voting shares following the cancellation of 1,009,204 shares purchased on June 18, 2025. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation for securities.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on treasury share holdings and voting rights calculations.